NewsBenzingaAxsome Therapeutics T3 BPA de $(0,25) dépasse l’estimation de $(0,56), les ventes de 259,691 M$ dépassent l’estimation de 249,929 M$ Axsome Therapeutics T3 BPA de $(0,25) dépasse l’estimation de $(0,56), les ventes de 259,691 M$ dépassent l’estimation de 249,929 M$ Benzinga 2026.11.02 12:01 (GMT+0) Open on Benzinga Other news Israeli Shipping Giant ZIM Cashes In on Surging Freight Rates, Raises Outlook UBS Maintains Buy on Home Depot, Lowers Price Target to $417 Disney Posts Upbeat Q4, Analysts Raise Price Target Citing Theme Park Resilience StoneX Maintains Buy on Bitdeer Techs, Lowers Price Target to $15 Merck Pulls Plug On Acquired Drug after Safety Review UBS Maintains Neutral on Granite Point Mortgage Tr, Lowers Price Target to $3